首页> 外文学位 >The design and synthesis of novel antimicrobial agents for use in the battle against bacterial resistance.
【24h】

The design and synthesis of novel antimicrobial agents for use in the battle against bacterial resistance.

机译:用于对抗细菌耐药性的新型抗菌剂的设计和合成。

获取原文
获取原文并翻译 | 示例

摘要

There is an ever increasing need to develop new antimicrobial agents with novel mechanisms of action. These new agents will help to combat the steady rise of antibiotic-resistant bacteria which are becoming more and more difficult to treat due to the dwindling number of antibiotics available to treat such organisms. This body of work brings to light the many ways in which medicinal chemistry plays a vital role in the discovery of novel antimicrobial agents. Chapter 1 is an introduction into antimicrobial agents. It provides a brief history of the discovery of antimicrobial agents, and delves into reasons why new agents are urgently needed. It also examines the recent antimicrobial agents approved by the Food and Drug Administration for use in the United States, and looks into the current antimicrobial drug pipeline. Chapter 2 explores the current therapy regime for combating tuberculosis and expresses the need for novel agents in this arena. It also shows how current medicinal chemistry techniques are being utilized to develop a novel class of potential anti-tuberculosis agents with novel mechanisms of action. Chapter 3 discusses the treatment of gram-negative bacterial infections with novel hybrid antimicrobial agents. These agents afford current antimicrobial agents, which have difficulty penetrating the gram-negative cell wall, a way into the gram-negative cell in order to exert their intended mechanism of action. This chapter explores the rationale and design behind the making of such agents. Chapter 4 provides an overview of the work detailed in the dissertation as well as future directions that will help further the scope of these projects.
机译:越来越需要开发具有新颖作用机制的新型抗菌剂。这些新药将有助于抵抗抗生素耐药性细菌的不断增加,由于可用于治疗此类生物体的抗生素数量的减少,这些细菌正变得越来越难以治疗。这项工作揭示了药物化学在发现新型抗菌剂中起着至关重要作用的多种方式。第1章介绍了抗菌剂。它提供了发现抗菌剂的简短历史,并探讨了迫切需要新药的原因。它还检查了美国食品药品监督管理局(FDA)批准在美国使用的最新抗微生物剂,并探讨了当前的抗微生物药物渠道。第2章探讨了当前的抗结核治疗方案,并表达了在这一领域对新型药物的需求。它还显示了如何利用当前的药物化学技术来开发具有新型作用机理的新型潜在抗结核药。第3章讨论了用新型杂合抗菌剂治疗革兰氏阴性细菌感染的方法。这些试剂提供了目前的抗微生物剂,它们难以穿透革兰氏阴性细胞壁,从而进入革兰氏阴性细胞以发挥其预期的作用机理。本章探讨了创建此类代理的原理和设计。第四章概述了论文中的工作以及未来的方向,这将有助于进一步扩大这些项目的范围。

著录项

  • 作者

    Brown, Joshua Randal.;

  • 作者单位

    The University of Tennessee Health Science Center.;

  • 授予单位 The University of Tennessee Health Science Center.;
  • 学科 Chemistry Organic.Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 105 p.
  • 总页数 105
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号